This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Learn what to consider for retirement in your 30s to effectively build wealth and secure your financial future. Start making informed choices now!
18,900 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Riot Platforms lit up the market in May with a dramatic 57% gain, riding AI computing demand and energy strategy news...
In the first half of 2026, SanDisk sprinted to the top of the market, earning the label sandisk stock biggest winner....
Greg Abel has stepped into Berkshire Hathaway’s top role with a plan that blends steady operations with a measured ap...
A new energy setback from the Iran conflict is reverberating worldwide. Global flows are disrupted, prices move, and ...
As AI enthusiasm shakes up the tech market, Microsoft stands out as a potentially steadier megacap. This article brea...
A groundbreaking collaboration could redefine how AI and space tech work together. This article examines what spacex'...
A hedge fund famous for bold bets shows a striking concentration: nearly half of its $14 billion stock portfolio sits...
UiPath faced a cautious session as its Korea cloud launch tests regional demand. This article breaks down what happen...
Could MaxLinear be the next stock to 10x? This guide breaks down the company, its AI hardware niche, and the realisti...
As Meta Platforms weighs renting out idle AI compute, investors ask if the company overbuilt. This piece breaks down ...
Nike has faced a tough run, but a turnaround could be on the horizon. This guide breaks down the factors to watch, re...